INR 145.5
(1.35%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 872.45 Million INR | -45.46% |
2022 | 525.1 Million INR | 68.11% |
2021 | 312.34 Million INR | 5.42% |
2020 | 296.27 Million INR | 4.08% |
2019 | 284.66 Million INR | 13.69% |
2018 | 250.38 Million INR | -4.59% |
2017 | 262.43 Million INR | -22.08% |
2016 | 336.81 Million INR | 7.31% |
2015 | 313.86 Million INR | -50.17% |
2014 | 629.89 Million INR | 9.51% |
2013 | 575.21 Million INR | -18.93% |
2012 | 709.53 Million INR | -85.69% |
2011 | 4.95 Billion INR | 932.11% |
2010 | 480.49 Million INR | -95.14% |
2009 | 9.88 Billion INR | 109.16% |
2008 | 4.72 Billion INR | -47.35% |
2007 | 8.98 Billion INR | 53.6% |
2006 | 5.84 Billion INR | 3.01% |
2005 | 5.67 Billion INR | 20.61% |
2004 | 4.7 Billion INR | -3.58% |
2003 | 4.88 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 65.7 Million INR | 4.6% |
2023 Q1 | 147.5 Million INR | 5.73% |
2023 FY | 286.4 Million INR | -45.46% |
2023 Q2 | 141.4 Million INR | -4.14% |
2023 Q3 | 161.8 Million INR | 14.43% |
2023 Q4 | 73.9 Million INR | -54.33% |
2022 Q4 | 139.5 Million INR | 10.63% |
2022 Q1 | 118 Million INR | 517.65% |
2022 Q2 | 141.5 Million INR | 19.92% |
2022 Q3 | 126.1 Million INR | -10.88% |
2022 FY | 525.1 Million INR | 68.11% |
2021 FY | 312.34 Million INR | 5.42% |
2021 Q4 | -28.25 Million INR | -125.59% |
2021 Q3 | 110.4 Million INR | -15.14% |
2021 Q2 | 130.1 Million INR | 29.97% |
2021 Q1 | 100.1 Million INR | 968.77% |
2020 Q2 | 105 Million INR | 1.65% |
2020 Q3 | 99.6 Million INR | -5.14% |
2020 FY | 296.27 Million INR | 4.08% |
2020 Q4 | -11.52 Million INR | -111.57% |
2020 Q1 | 103.3 Million INR | 584.2% |
2019 Q3 | 102.6 Million INR | 6.76% |
2019 Q2 | 96.1 Million INR | -10.44% |
2019 Q4 | -21.33 Million INR | -120.79% |
2019 FY | 284.66 Million INR | 13.69% |
2019 Q1 | 107.3 Million INR | 305.1% |
2018 Q3 | 90.7 Million INR | -22.28% |
2018 Q2 | 116.7 Million INR | 22.46% |
2018 Q1 | 95.3 Million INR | -28.72% |
2018 FY | 250.38 Million INR | -4.59% |
2018 Q4 | -52.31 Million INR | -157.68% |
2017 FY | 262.43 Million INR | -22.08% |
2017 Q4 | 133.7 Million INR | 0.0% |
2016 Q4 | 108.7 Million INR | 0.0% |
2016 FY | 336.81 Million INR | 7.31% |
2015 Q3 | 107.3 Million INR | 3.37% |
2015 Q2 | 103.8 Million INR | -57.04% |
2015 Q1 | 241.6 Million INR | 55.57% |
2015 FY | 313.86 Million INR | -50.17% |
2015 Q4 | 122.8 Million INR | 14.45% |
2014 FY | 629.89 Million INR | 9.51% |
2014 Q2 | 296.2 Million INR | 114.79% |
2014 Q3 | 181.8 Million INR | -38.62% |
2014 Q4 | 155.29 Million INR | -14.58% |
2014 Q1 | 137.9 Million INR | 276.65% |
2013 Q1 | 110.9 Million INR | -37.43% |
2013 Q4 | 36.61 Million INR | -82.18% |
2013 Q3 | 205.4 Million INR | 1.03% |
2013 Q2 | 203.3 Million INR | 83.32% |
2013 FY | 575.21 Million INR | -18.93% |
2012 Q3 | 201.6 Million INR | 2.13% |
2012 Q4 | 177.23 Million INR | -12.09% |
2012 FY | 709.53 Million INR | -85.69% |
2012 Q1 | 150.5 Million INR | -96.57% |
2012 Q2 | 197.4 Million INR | 31.16% |
2011 Q3 | 182.5 Million INR | 0.0% |
2011 FY | 4.95 Billion INR | 932.11% |
2011 Q4 | 4.38 Billion INR | 2304.04% |
2010 FY | 480.49 Million INR | -95.14% |
2009 FY | 9.88 Billion INR | 109.16% |
2008 Q4 | 1.24 Billion INR | 0.0% |
2008 FY | 4.72 Billion INR | -47.35% |
2007 FY | 8.98 Billion INR | 53.6% |
2006 FY | 5.84 Billion INR | 3.01% |
2005 FY | 5.67 Billion INR | 20.61% |
2004 FY | 4.7 Billion INR | -3.58% |
2003 FY | 4.88 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | -50.453% |
Ind-Swift Limited | 946.56 Million INR | 7.829% |
Bajaj HealthCare Limited | 985.34 Million INR | 11.457% |
Sakar Healthcare Limited | 204.07 Million INR | -327.51% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.432% |
Innova Captab Limited | 931.03 Million INR | 6.291% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.843% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 64.728% |
Morepen Laboratories Limited | 1.98 Billion INR | 56.102% |
Mankind Pharma Limited | 29.27 Billion INR | 97.02% |
Sequent Scientific Limited | 2.9 Billion INR | 69.934% |
Wanbury Limited | 978.96 Million INR | 10.88% |
Laurus Labs Limited | 11.9 Billion INR | 92.674% |
Nectar Lifesciences Limited | 932.7 Million INR | 6.459% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 92.505% |
Hikal Limited | 4.46 Billion INR | 80.455% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.502% |
Neuland Laboratories Limited | 2.92 Billion INR | 70.221% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 94.102% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.142% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 60.361% |
Themis Medicare Limited | 1.12 Billion INR | 22.503% |
RPG Life Sciences Limited | 1.63 Billion INR | 46.655% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.303% |
Lupin Limited | 125.09 Billion INR | 99.303% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 58.336% |
Wockhardt Limited | 8.48 Billion INR | 89.712% |
Vaishali Pharma Limited | 84.02 Million INR | -938.282% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 71.622% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -98.942% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.964% |
FDC Limited | 3.49 Billion INR | 75.071% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.09% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -111.542% |
Eris Lifesciences Limited | 4.94 Billion INR | 82.349% |
Venus Remedies Limited | 1.91 Billion INR | 54.471% |
ZIM Laboratories Limited | 1.01 Billion INR | 13.879% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 38.526% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1396.805% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 59.878% |
Shilpa Medicare Limited | 3.33 Billion INR | 73.833% |
Albert David Limited | 1.02 Billion INR | 14.977% |
Ajanta Pharma Limited | 30.46 Billion INR | 97.136% |
Hester Biosciences Limited | 908.84 Million INR | 4.003% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 37.805% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 65.841% |
Gufic Biosciences Limited | 1.18 Billion INR | 26.473% |
Windlas Biotech Limited | 1 Billion INR | 13.318% |
Procter & Gamble Health Limited | 2.99 Billion INR | 70.873% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6038.451% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -437.797% |
Granules India Limited | 10.31 Billion INR | 91.54% |
Aarti Drugs Limited | 1.16 Billion INR | 25.27% |
Bal Pharma Limited | 555.62 Million INR | -57.023% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.343% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.434% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 18.78% |
Medicamen Biotech Limited | 335.16 Million INR | -160.305% |
Unichem Laboratories Limited | 6.72 Billion INR | 87.028% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -91.503% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -12692.639% |
Valiant Laboratories Limited | 138.02 Million INR | -532.083% |
Orchid Pharma Limited | 800.77 Million INR | -8.952% |
Medico Remedies Limited | 59.67 Million INR | -1362.016% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 58.927% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.405% |
Brooks Laboratories Limited | 51.18 Million INR | -1604.685% |
Syncom Formulations (India) Limited | 345.63 Million INR | -152.423% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.629% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.927% |
NATCO Pharma Limited | 10.05 Billion INR | 91.326% |
Suven Life Sciences Limited | 109.75 Million INR | -694.95% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1790.237% |
Strides Pharma Science Limited | 9.16 Billion INR | 90.478% |
Indoco Remedies Limited | 12.06 Billion INR | 92.766% |
Alpa Laboratories Limited | 127.38 Million INR | -584.925% |
Lasa Supergenerics Limited | 291.17 Million INR | -199.635% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 71.644% |